Rasagiline Tablet
Product Images NDC 83085-008

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Rasagiline (NDC 83085-008). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Skg Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Debossing Code 0.5 mg (Code 0.5 mg)

Debossing Code 0.5 mg (Code 0.5 mg)
The image shows a circular imprint on a tablet with the marking 'L 0.5'. This indicates a Rasagiline oral tablet with a strength of 0.5 mg, consistent with the product Rasagiline mesylate by SKG Pharma Inc.*
FDA Label Image

Debossing Code 1 mg (Code 1 mg)

Debossing Code 1 mg (Code 1 mg)
Rasagiline tablet with a white, round shape and an imprint containing 'L1'. The image focuses on the physical appearance of the tablet, showing the imprint clearly but without additional packaging or labeling information.*
FDA Label Image

0.5 mg-30 Tablets Bottle Label (Image001)

0.5 mg-30 Tablets Bottle Label (Image001)
Packaging label for Rasagiline Tablets 0.5 mg oral tablets, containing 30 tablets per container. The label indicates the product is distributed by SKG Pharma Inc., South Plainfield, NJ, and made in India. It includes storage instructions and mentions the product is child-resistant.*
FDA Label Image

0.5 mg-500 Tablets Bottle Label (Image002)

0.5 mg-500 Tablets Bottle Label (Image002)
Label for Rasagiline tablets 0.5 mg by SKG Pharma Inc. The label states a package size of 500 tablets and includes a barcode. It notes storage instructions, dosage information, and that the container has a child-resistant closure. The product is made in India and distributed by SKG Pharma Inc. in South Plainfield, NJ.*
FDA Label Image

0.5 mg-1,000 Tablets Bottle Label (Image003)

0.5 mg-1,000 Tablets Bottle Label (Image003)
Label for Rasagiline 0.5 mg oral tablets, containing 1,000 tablets per container. The label lists Rasagiline mesylate as the active ingredient equivalent to 0.5 mg Rasagiline. It includes storage instructions, dosing reference, and child-resistant closure warning. Distributed by SKG Pharma Inc., located in South Plainfield, New Jersey, with manufacturing origin stated as India.*
FDA Label Image

1 mg-30 Tablets Bottle Label (Image004)

1 mg-30 Tablets Bottle Label (Image004)
Label for Rasagiline Tablets, 1 mg strength, oral tablets. The label indicates the package contains 30 tablets and is distributed by SKG Pharma Inc. It includes storage instructions for child-resistant packaging and temperature control. The label also states the product is Rx only and made in India.*
FDA Label Image

1 mg-500 Tablets Bottle Label (Image005)

1 mg-500 Tablets Bottle Label (Image005)
Rasagiline Tablets 1 mg oral tablets labeled by SKG Pharma Inc. The label states each tablet contains 1 mg rasagiline equivalent to 1.56 mg rasagiline mesylate. The package contains 500 tablets and is for prescription use only. Storage instructions and distributor details are also printed on the label.*
FDA Label Image

1 mg-1,000 Tablets Bottle Label (Image006)

1 mg-1,000 Tablets Bottle Label (Image006)
Rasagiline Tablets 1 mg oral tablets label contains 1,000 count and is distributed by SKG Pharma Inc. The label includes dosage strength, Rx-only status, storage instructions, and child-resistant container information. It also lists the product as made in India with the NDC 83085-008-10 visible near the top.*
FDA Label Image

Chemical Structure (Strcuture001)

Chemical Structure (Strcuture001)
Chemical structure diagram of rasagiline mesylate, showing the molecular components including a bicyclic ring and a methylsulfonic acid group (CH3SO3H).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.